Search

Brooks Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 62.80 -3.45  | -5.21% -38.46% - 101.97
NSE Price: Nov 15, 15:52 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 15, 15:52 62.80 -3.45 -5.21% 65.95 66.25 36,777 61.60 - 67.70
BSE Nov 15, 2018 63.00 -3.20 -4.83% 66.50 66.20 13,533 61.60 - 66.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 82,864 P/B: 0.92 NSE Code: BROOKS
52-Week Range: R 47.65 - 122.75 Dividend Yield: 0.00% BSE Code: 533543
TTM EPS: R -7.18 Book Value: R 68.43 Face Value: R 10
Price Graph
  • Merck (NSE)
  • NIFTY 50


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Brooks Laboratories -44.25 11.35 -23.55 -38.46 -2.39 28.64 -
NIFTY Smallcap 100 -31.05 2.59 -16.33 -24.36 6.04 15.16 13.80
NIFTY Pharma -4.17 -5.68 -2.77 2.14 -7.46 4.32 14.79
Company's return has been calculated on basis of NSE's price.
As on Nov 15, 2018
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -3.18 -13.21 -7.01
Net Profit -928.65 -213.42 -214.10
EPS -928.67 -213.42 -214.10
Book Value -10.76 0.91 2.31
Average
Operating Margin -15.52 3.08 5.99
Net Margin -24.69 -2.92 2.11
Return on Networth -11.38 -0.31 2.90
Return on Investment -10.61 0.56 3.74
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -26.47 27.85 -26.47
Operating Profit -103.40 3.40 -103.40
Net Profit -64.19 36.80 -64.19
EPS -64.19 36.80 -64.19
TTM
Revenue 4.09 2.50 4.09
Operating Profit 1.34 -620.86 1.34
Net Profit 15.69 -98.89 15.69
EPS 15.69 -98.89 15.69
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Brooks Laboratories 101.97 59.23 -11.62 -19.45 -11.38 0.92 -
Astrazeneca Pharma India 4,179.13 602.06 8.39 1.37 11.12 15.86 497.87
Merck 4,957.90 1,051.73 150.62 11.53 13.44 6.09 40.01
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 17, 2018 Aryan Mahanjan  Buy Preferential Allotment 212,500 78.25 166.28
Sep 17, 2018 Mr Aryan Mahajan  Buy Preferential Offer 212,500 78.25 166.28
Sep 10, 2018 Rajni Ranchal  Buy Preferential Allotment 212,500 80.75 171.59
Sep 10, 2018 Saras Gupta  Buy Preferential Allotment 212,500 80.75 171.59
Sep 10, 2018 Savvy Ranchal  Buy Preferential Allotment 212,500 80.75 171.59
News & Announcements
Contact Information

Company: Brooks Laboratories Ltd.

Address: Village Kishanpura, Nalagarh Road, Baddi, Solan Dist, Himachal Pradesh - 174101 | Phone: 01795- 654001/02/03 | Fax: 01795-236939

Email: [email protected]

Website: www.brookslabs.net

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

comments powered by Disqus
Essential checks
Altman Z-Score
1.87
Piotroski F-Score
2
Modified C-Score
2
5-Years Price to Earnings
Not applicable
5-Years Price to Book
0.97
Earnings Yield
EBIT / Enterprise value
-11.29%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R1,690.45 +0.54%
Caplin Point Laboratories R430.40 +0.46%
Dishman Carbogen Amcis R227.45 -0.09%
FDC R192.40 -3.10%
JB Chemicals & Pharma R308.65 -0.68%
Laurus Labs R382.25 +2.36%
Merck R2,999.70 +0.33%
Shilpa Medicare R373.90 -1.68%
Strides Pharma Science R457.75 -0.08%
Suven Life Sciences R256.25 +3.26%
As on Nov 15, 15:59